Beckman Coulter Life Sciences Acquisition Expands Flow Cytometry Line
18 Apr 2012

Beckman Coulter Life Sciences has announced the acquisition of Blue Ocean Biomedical, LLC, a Pembroke Pines, Florida-based manufacturer of automated flow cytometry systems and reagents. The development will provide Beckman Coulter Life Sciences with low complexity analyzers that integrate automated sample preparation.

Blue Ocean Biomedical products complement Beckman Coulter’s cytometry portfolio with instruments based on a “sample in, result out” (SIRO) approach that represents a fundamental change in the routine clinical analysis sector. These products provide the first true integration of sample preparation, handling, analysis and data management, and are the only SIRO solution for clinical flow cytometry.

“This acquisition provides both immediate opportunity and long-term value,” said Scott Atkin, president, Beckman Coulter Life Sciences. “The simplification of customer workflows will be dramatic. We’ll be able to offer customers an extended line of market leading technology while expanding our reach within a key segment for flow cytometry.”

“Our team has developed a line of truly unique instrument systems: essentially, the world’s first ‘load & go™’ flow cytometers,” said Mike Brochu, CEO and co-founder of Blue Ocean Biomedical. “With its history of leadership and innovation in this field, Beckman Coulter has all the resources and technology needed to build on this platform and future systems for years to come.”

The systems and reagents are currently not available in the U.S.; for distribution in the European Union only.

Request Info


Company website

Tags: SIRO

Beckman Coulter
profile photo

Sonia Nicholas
Clinical Diagnostics Editor